Form 4 for ALDX Aldeyra Therapeutics, Inc.
Accepted 2023-09-11 00:00:00 ET · period of report 2023-09-07 · accession 0000950170-23-047497 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-09-11 | 2023-09-07 | ALDX | Phillips Gary M. | Dir | M - OptEx | $0.55 | +5,437 | 14.8K | +58% | +$2,990 |
| D | 2023-09-11 | 2023-09-07 | ALDX | Phillips Gary M. | Dir | M - OptEx | $0.00 | -5,437 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-07 | M | A | 5,437 | $0.55 | 14,812 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-09-07 | M | D | 5,437 | $0.00 | 0 | D | $0.55 · — to 2023-09-07 | 5,437 Common Stock | (F1) The stock option is fully vested. |